title: Gonorrhea as a moving target: how do we sharpen our aim and strengthen our arrows?
authors.affiliation: Department of Obstetrics and Gynecology, St. Michael's Hospital, University of Toronto, Toronto ON.
authors.forename: Mark H
authors.initials: MH
authors.lastname: Yudin
authors.affiliation: British Columbia Centre for Disease Control, Vancouver BC; University of British Columbia, Vancouver BC.
authors.forename: Travis
authors.initials: T
authors.lastname: Salway Hottes
authors.affiliation: British Columbia Centre for Disease Control, Vancouver BC; University of British Columbia, Vancouver BC.
authors.forename: Gina S
authors.initials: GS
authors.lastname: Ogilvie
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002170:Canada / Q000453:epidemiology; D018550:Cephalosporin Resistance; D002511:Cephalosporins / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins